Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jun-ichi Hirai is active.

Publication


Featured researches published by Jun-ichi Hirai.


Journal of the American College of Cardiology | 1997

Quantitative Rest Technetium-99m Tetrofosmin Imaging in Predicting Functional Recovery After Revascularization: Comparison With Rest–Redistribution Thallium-201

Matsunari I; Susumu Fujino; Junichi Taki; Junji Senma; Takahiko Aoyama; Takanobu Wakasugi; Jun-ichi Hirai; Takashi Saga; Shinichiro Yamamoto; Norihisa Tonami

OBJECTIVESnThis study was undertaken to 1) compare the regional myocardial tracer distributions between rest technetium (Tc)-99m tetrofosmin and rest-redistribution thallium (Tl)-201 images in patients with coronary artery disease and left ventricular dysfunction; and 2) assess the comparative values of these agents for predicting functional recovery after revascularization.nnnBACKGROUNDnTc-99m tetrofosmin is a new myocardial perfusion imaging agent, but its role for detecting viable myocardium is still unclear.nnnMETHODSnThirty-six patients with coronary artery disease and left ventricular dysfunction underwent rest Tc-99m tetrofosmin, rest-redistribution Tl-201 and gated blood pool scintigraphy. In 21 patients with successful revascularization confirmed by follow-up angiography, gated blood pool scintigraphy was repeated after revascularization. Optimal threshold cutoffs to separate reversible from irreversible dysfunction were determined by receive operating characteristic analysis.nnnRESULTSnRegional Tc-99m tetrofosimin activity highly correlated with redistribution Tl-201 activity (r = 0.93). The diagnostic performance for predicting functional recovery, as measured by the area under the receiver operating characteristic curves, measured 0.66 +/- 0.07 (mean +/- SD) for Tc-99m tetrofosmin and 0.67 +/- 0.07 for Tl-201 (p = 0.60, 96.7% power to detect difference in area of 0.10). The optimal threshold cutoffs for viability were considered to be 50% of peak activity for Tc-99m tetrofosmin and 55% of peak activity for Tl-201. The positive and negative predictive values for reversible dysfunction were, respectively, 69% and 82% for Tc-99m tetrofosmin and 69% (p = 0.99 vs. Tc-99m tetrofosmin) and 71% (p = 0.66 vs. Tc-99m tetrofosmin) by Tl-201.nnnCONCLUSIONSnThe diagnostic performance of quantitative rest Tc-99m tetrofosmin imaging in predicting functional recovery after revascularization is comparable to that of rest-redistribution Tl-201.


The Journal of Nuclear Medicine | 1995

Myocardial Viability Assessment with Technetium-99m-Tetrofosmin and Thallium-201 Reinjection in Coronary Artery Disease

Ichiro Matsunari; Susumu Fujino; Junichi Taki; Junji Senma; Takahiko Aoyama; Takanobu Wakasugi; Jun-ichi Hirai; Takashi Saga; Kenji Ichiyanagi; Kinichi Hisada


The Journal of Nuclear Medicine | 1995

Improved Myocardial Fatty Acid Utilization after Percutaneous Transluminal Coronary Angioplasty

Ichiro Matsunari; Takashi Saga; Junichi Taki; Yoshihiro J. Akashi; Jun-ichi Hirai; Takanobu Wakasugi; Takahiko Aoyama; Munetaka Matoba; Kenji Ichiyanagi; Kinichi Hisada


The Journal of Nuclear Medicine | 1997

Significance of Late Redistribution Thallium-201 Imaging after Rest Injection for Detection of Viable Myocardium

Ichiro Matsunari; Susumu Fujino; Junichi Taki; Junji Senma; Takahiko Aoyama; Takanobu Wakasugi; Jun-ichi Hirai; Takashi Saga; Shinichiro Yamamoto; Norihisa Tonami


Japanese Circulation Journal-english Edition | 1999

Residual Cardiomyocytes and Scintigraphic Findings in Advanced Coronary Artery Disease

Susumu Fujino; Ichiro Matsunari; Takashi Saga; Hideaki Okazaki; Tatsuo Haraki; Takahiko Aoyama; Jun-ichi Hirai; Kenji Doishita; Noboru Takekoshi


Japanese Circulation Journal-english Edition | 1999

Residual cardiomyocytes and scintigraphic findings in advanced coronary artery disease: correlation with technetium-99m-tetrofosmin and thallium-201 single photon emission computed tomography.

Susumu Fujino; Ichiro Matsunari; Takashi Saga; Hideaki Okazaki; Tatsuo Haraki; Takahiko Aoyama; Jun-ichi Hirai; Kenji Doishita; Noboru Takekoshi


Japanese Journal of Thrombosis and Hemostasis | 1978

The changes of fibrin stabilizing factor levels in myocardial infarction

Takeshi Morishita; Toru Shindo; Syun Hasegawa; Jun-ichi Hirai; Shinichiro Suzuki; Michizo Koizumi; Mitsuru Amanuma; Tatsuo Shirai; Isao Urayama


/data/revues/00029149/v77i5/S0002914997893629/ | 2011

Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease

Ichiro Matsunari; Susumu Fujino; Junichi Taki; Junji Senma; Takahiko Aoyama; Takanobu Wakasugi; Jun-ichi Hirai; Takashi Saga; Norihisa Tonami; Kinichi Hisada


/data/revues/00028703/v131i3/S0002870396905232/ | 2011

Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection

Ichiro Matsunari; Susumu Fujino; Junichi Taki; Junji Senma; Takahiko Aoyama; Takanobu Wakasugi; Jun-ichi Hirai; Takashi Saga; Kenji Ichiyanagi; Kinichi Hisada


Japanese Circulation Journal-english Edition | 2007

OE-025 Left Atrial Substrate Modification for Paroxysmal Atrial Fibrillation : Comparison of Two Different Strategies for Catheter Ablation Using CARTO Navigation(Arrhythmia, therapy-01, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

Hiroshi Kato; Yuka Sugawara; Jun-ichi Hirai; Teiji Ohnishi; Naomi Maekawa; Hidehiro Takahshi; Masaki Dochin; Shigeyuki Wakahara; Makoto Yamamoto

Collaboration


Dive into the Jun-ichi Hirai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge